Outcomes of octogenarians with esophageal cancer: an analysis of the National Cancer Database

被引:10
|
作者
Bakhos, C. T. [1 ,2 ]
Salami, A. C. [2 ]
Kaiser, L. R. [1 ]
Petrov, R. V. [1 ]
Abbas, A. E. [1 ]
机构
[1] Temple Univ Hosp & Med Sch, Dept Thorac Med & Surg, Philadelphia, PA 19140 USA
[2] Albert Einstein Healthcare Network, Dept Surg, Philadelphia, PA USA
关键词
esophagectomy; geriatric; population; survival; trimodality therapy; ELDERLY-PATIENTS; PREOPERATIVE CHEMORADIOTHERAPY; MORTALITY; AGE; CHEMOTHERAPY; FEASIBILITY; CARCINOMA; MORBIDITY; RESECTION; SURGERY;
D O I
10.1093/dote/doy128
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The optimal treatment of esophageal cancer in octogenarians is controversial. While the safety of esophagectomy has been demonstrated in elderly patients, surgery and multimodality therapy are still offered to a select group. Additionally, the long-term outcomes in octogenarians have not been thoroughly compared to those in younger patients. We sought to compare the outcomes of esophageal cancer treatment between octogenarians and non-octogenarians in the National Cancer Database (2004-2014). The major endpoints were early postoperative mortality and long-term survival. A total of 107,921 patients were identified [octogenarian-16,388 (15.2%)]. Compared to non-octogenarians, octogenarians were more likely to be female, of higher socioeconomic status, and had more Charlson comorbidities (p < 0.001 for all). Octogenarians were significantly less likely to undergo esophagectomy (11.5% vs. 33.3%; p < 0.001) and multimodality therapy (2.0% vs. 18.5%; p < 0.001), a trend that persisted following stratification by tumor stage and Charlson comorbidities. Both 30-day and 90-day mortality were higher in the octogenarian group, even after multivariable adjustment (p <= 0.001 for both). Octogenarians who underwent multimodality therapy had worse long-term survival when compared to younger patients, except for those with stage III tumors and no comorbidities (HR: 1.29; p = 0.153). Within the octogenarian group, postoperative mortality was lower in academic centers, and the long-term survival was similar between multimodality treatment and surgery alone (HR: 0.96; p = 0.62). In conclusion, octogenarians are less likely to be offered treatment irrespective of tumor stage or comorbidities. Although octogenarians have higher early mortality and poorer overall survival compared to younger patients, outcomes may be improved when treatment is performed at academic centers. Multimodality treatment did not seem to confer a survival advantage compared to surgery alone in octogenarians, and more prospective studies are necessary to better elucidate the optimal treatment in this patient population.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [31] Patterns of care and outcomes in gliosarcoma: an analysis of the National Cancer Database
    Frandsen, Jonathan
    Orton, Andrew
    Jensen, Randy
    Colman, Howard
    Cohen, Adam L.
    Tward, Jonathan
    Shrieve, Dennis C.
    Suneja, Gita
    JOURNAL OF NEUROSURGERY, 2018, 128 (04) : 1133 - 1138
  • [32] BENEFIT OF POST-RESECTION ADJUVANT CHEMOTHERAPY FOR STAGE III COLON CANCER IN OCTOGENARIANS: ANALYSIS OF THE NATIONAL CANCER DATABASE
    Bergquist, J.
    Thiels, C.
    Spindler, B.
    Hayman, A.
    Habermann, E.
    Pemberton, J.
    Mathis, K.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E81 - E82
  • [33] Clinical Factors and Outcomes of Octogenarians Receiving Curative Surgery for Esophageal Cancer
    Song, Ethan Y.
    Frakes, Jessica M.
    Extermann, Martine
    Klocksieben, Farina
    Mehta, Rutika
    Saeed, Sabrina
    Hoffe, Sarah E.
    Pimiento, Jose M.
    JOURNAL OF SURGICAL RESEARCH, 2020, 251 : 100 - 106
  • [34] Cervical Esophageal Cancer: A Comparison of Outcomes by Treatment Paradigm, Tumor Location, and Histology Using the National Cancer Database
    Torgeson, A. M.
    Francis, S.
    Lloyd, S.
    Hitchcock, Y. J.
    Cannon, G. M.
    Avizonis, V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1334 - 1334
  • [35] Outcomes of invasive primary urethral cancer in women: An analysis from the national cancer database
    Ganiyani, M. A.
    Podder, V.
    Avudaiappan, Pon A.
    Khosla, A. A.
    Prabhakar, P.
    Ozair, A.
    Ahmad, S.
    Rubens, M.
    Roy, M.
    Manoharan, M.
    Garje, R.
    EUROPEAN UROLOGY, 2024, 85 : S1384 - S1385
  • [36] Utilization and outcomes of metastasectomy for patients with metastatic urothelial cancer: An analysis of the national cancer database
    Dursun, Furkan
    Mackay, Alexander
    Guzman, Jonathan C. A.
    Wenker, Evan
    Klaassen, Zachary
    O'Malley, Padraic
    Bhindi, Bimal
    Perez, Cinthya Obando
    Xu, Jiaqiong
    Roh, Taehyun
    Sonpavde, Guru
    Wallis, Christopher J. D.
    Satkunasivam, Raj
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (02) : 61.e21 - 61.e28
  • [37] Comparison of facility type outcomes for oral cavity cancer: Analysis of the national cancer database
    Rubin, Samuel J.
    Cohen, Michael B.
    Kirke, Diana N.
    Qureshi, Muhammad M.
    Minh Tam Truong
    Jalisi, Scharukh
    LARYNGOSCOPE, 2017, 127 (11): : 2551 - 2557
  • [38] Analysis of the National Cancer Database Esophageal Squamous Cell Carcinoma in the United States
    Chapman, Brandon C.
    Weyant, Michael
    Hilton, Sarah
    Hosokawa, Patrick W.
    McCarter, Martin D.
    Gleisner, Ana
    Nader, Nader D.
    Gajdos, Csaba
    ANNALS OF THORACIC SURGERY, 2019, 108 (05): : 1535 - 1542
  • [39] The Role of Immunotherapy in the Management of Esophageal Cancer in Patients Treated with Neoadjuvant Chemoradiation: An Analysis of the National Cancer Database
    Tasoudis, Panagiotis
    Manaki, Vasiliki
    Iwai, Yoshiko
    Buckeridge, Steven A.
    Khoury, Audrey L.
    Agala, Chris B.
    Haithcock, Benjamin E.
    Mody, Gita N.
    Long, Jason M.
    CANCERS, 2024, 16 (13)
  • [40] Using the National Cancer Database for Outcomes Research
    Boffa, Daniel J.
    Rosen, Joshua E.
    Mallin, Katherine
    Loomis, Ashley
    Gay, Greer
    Palis, Bryan
    Thoburn, Kathleen
    Gress, Donna
    McKellar, Daniel P.
    Shulman, Lawrence N.
    Facktor, Matthew A.
    Winchester, David P.
    JAMA ONCOLOGY, 2017, 3 (12) : 1722 - 1728